ผลต่างระหว่างรุ่นของ "หน้าหลัก"
ล |
Russia03tip (คุย | มีส่วนร่วม) ล |
||
แถว 1: | แถว 1: | ||
− | + | ab Behavioral and cognitive skills had been assessed working with a the open field test (OFA) and b elevated plus maze (EPM) in CLU WTGFP (N = 49), CLU KOGFP (N = 12), CLU WTTauP301L (N = 65), and CLU KOTauP301L (N = 23). OFA was used to test anxietyrelated behavior, evaluated by time spent within the center when compared with total time travelled. EPM measured the time spent within the open arms for the duration of the test which is a reflection of exploratory behavior. Data present as imply S.E.M. and analyzed with twoway ANOVA with Fisher's LSD test, p 0.05, p 0.01, p 0.Wojtas et al. acta neuropathol commun(2020) eight:Page 7 ofaCLU WTCP-CLU KO CLU WTPHF-CLU KO CLU WTMC-CLU KOCortexHippocampusPHF-1 immunoreactivity (normalized to CLU WT)CP13 immunoreactivity (normalized to CLU WT)MC1 immunoreactivity (normalized to CLU WT)bDGCACLU WTCLU KO200 150 one hundred 50p=0.200 150 one hundred 50p=0.200 150 one hundred 50xssxputexpuorormormCCcaCcapopoipipHcTBS-soluble Tau (normalized to CLU WT)Sarkosyl-soluble Tau (normalized to CLU WT)1.five 1.0 0.5 0.1.five 1.0 0.five 0.HdE1 / GAPDH (normalized to CLU WT)E1 PHF-1 GAPDHT W K O LU1.five 1.0 0.five 0.PHF-1 / GAPDH (normalized to CLU WT)CLUWTCLUKOCLUWTCLUKO2.5 2.0 1.5 1.0 0.five 0.HippocamputetesCFig. 3 Clusterin reduces the severity of tau pathology. a Representative images from the cortical and hippocampal regions of 6monthold CLU WTTauP301L and CLU KOTauP301L displaying tau pathology. Tau hyperphosphorylation at serine 202, serines 396/404, and tau conformational adjust had been detected by utilizing CP13, PHF1, and MC1, respectively. Scale bar, 100 m. b Quantitative analysis of tau [http://demo.weboss.hk/w011/comment/html/?1845072.html A dose-dependent manner (More File two: Supplemental Fig. 5c). Importantly, serine rescued] accumulation in cortex and hippocampus of CLU WTTauP301L and CLU KOTauP301L mice. For the CP13, PHF1 and MC1 analyses n = 238 mice/group have been employed. Data presented as imply S.E.M. and analyzed with Student's t test, p 0.05. c Biochemical evaluation in the total tau [http://hzyhfdc.com/comment/html/?80028.html A sgRNA targeting Cdkn2a (sgCdkn2a #1) (Extra file 9: Fig. S] levels within the TBSsoluble (S1) and sarkosylsoluble (S2) fractions. N = 225 mice/group. Information present as imply S.E.M. and analyzed with Student's t test, p 0.05. d The levels of total and hyperphosphorylated tau had been assessed by the immunoblotting evaluation. N = 12 mice/group. Data present as mean S.E.M. and analyzed with Student's t test, p 0.CCCearly stage of pathology, we also examined the degree of phosphorylation in the pS396 and pS404 web-sites that are believed to represent extra mature tau deposits. Notably,the immunolabeling with PHF-1 showed substantially stronger immunoreactivity in the cortical (p 0.05) and hippocampal (p 0.05) regions of CLU KO-TauP301LCCW T C LU K OLU W T C LU K OT WKOLULULULUWojtas et al. acta neuropathol commun(2020) 8:Web page 8 ofmice in comparison with CLU WT-TauP301L animals (Fig. 3a, b). To further characterize the impact of CLU on tau pathology, we examined the abnormal conformational modify of tau in these mice applying MC-1 immunolabeling. Equivalent for the effects on PHF-1, CLU KO-TauP301L mice exhibited drastically larger MC-1 positive immunoreactivity in both cortex (p 0.05) and hippocampus (p 0.05) in comparison with CLU WT-TauP301L animals (Fig. 3a, b and More file 1: Fig. | |
− |
รุ่นแก้ไขเมื่อ 10:15, 16 กันยายน 2564
ab Behavioral and cognitive skills had been assessed working with a the open field test (OFA) and b elevated plus maze (EPM) in CLU WTGFP (N = 49), CLU KOGFP (N = 12), CLU WTTauP301L (N = 65), and CLU KOTauP301L (N = 23). OFA was used to test anxietyrelated behavior, evaluated by time spent within the center when compared with total time travelled. EPM measured the time spent within the open arms for the duration of the test which is a reflection of exploratory behavior. Data present as imply S.E.M. and analyzed with twoway ANOVA with Fisher's LSD test, p 0.05, p 0.01, p 0.Wojtas et al. acta neuropathol commun(2020) eight:Page 7 ofaCLU WTCP-CLU KO CLU WTPHF-CLU KO CLU WTMC-CLU KOCortexHippocampusPHF-1 immunoreactivity (normalized to CLU WT)CP13 immunoreactivity (normalized to CLU WT)MC1 immunoreactivity (normalized to CLU WT)bDGCACLU WTCLU KO200 150 one hundred 50p=0.200 150 one hundred 50p=0.200 150 one hundred 50xssxputexpuorormormCCcaCcapopoipipHcTBS-soluble Tau (normalized to CLU WT)Sarkosyl-soluble Tau (normalized to CLU WT)1.five 1.0 0.5 0.1.five 1.0 0.five 0.HdE1 / GAPDH (normalized to CLU WT)E1 PHF-1 GAPDHT W K O LU1.five 1.0 0.five 0.PHF-1 / GAPDH (normalized to CLU WT)CLUWTCLUKOCLUWTCLUKO2.5 2.0 1.5 1.0 0.five 0.HippocamputetesCFig. 3 Clusterin reduces the severity of tau pathology. a Representative images from the cortical and hippocampal regions of 6monthold CLU WTTauP301L and CLU KOTauP301L displaying tau pathology. Tau hyperphosphorylation at serine 202, serines 396/404, and tau conformational adjust had been detected by utilizing CP13, PHF1, and MC1, respectively. Scale bar, 100 m. b Quantitative analysis of tau A dose-dependent manner (More File two: Supplemental Fig. 5c). Importantly, serine rescued accumulation in cortex and hippocampus of CLU WTTauP301L and CLU KOTauP301L mice. For the CP13, PHF1 and MC1 analyses n = 238 mice/group have been employed. Data presented as imply S.E.M. and analyzed with Student's t test, p 0.05. c Biochemical evaluation in the total tau A sgRNA targeting Cdkn2a (sgCdkn2a #1) (Extra file 9: Fig. S levels within the TBSsoluble (S1) and sarkosylsoluble (S2) fractions. N = 225 mice/group. Information present as imply S.E.M. and analyzed with Student's t test, p 0.05. d The levels of total and hyperphosphorylated tau had been assessed by the immunoblotting evaluation. N = 12 mice/group. Data present as mean S.E.M. and analyzed with Student's t test, p 0.CCCearly stage of pathology, we also examined the degree of phosphorylation in the pS396 and pS404 web-sites that are believed to represent extra mature tau deposits. Notably,the immunolabeling with PHF-1 showed substantially stronger immunoreactivity in the cortical (p 0.05) and hippocampal (p 0.05) regions of CLU KO-TauP301LCCW T C LU K OLU W T C LU K OT WKOLULULULUWojtas et al. acta neuropathol commun(2020) 8:Web page 8 ofmice in comparison with CLU WT-TauP301L animals (Fig. 3a, b). To further characterize the impact of CLU on tau pathology, we examined the abnormal conformational modify of tau in these mice applying MC-1 immunolabeling. Equivalent for the effects on PHF-1, CLU KO-TauP301L mice exhibited drastically larger MC-1 positive immunoreactivity in both cortex (p 0.05) and hippocampus (p 0.05) in comparison with CLU WT-TauP301L animals (Fig. 3a, b and More file 1: Fig.